Lab worker dropping liquid onto microscope slide
Lab worker dropping liquid onto microscope slide

ASH 2022

OVERVIEW

10 - 13

Dec 2022

ASH 2022

New Orleans, LA

World’s largest network supporting clinical and scientific hematology research.

PELABRESIB PRESENTATIONS

  • Oral Presentation

    Pelabresib (CPI-0610) Combined With Ruxolitinib for JAK Inhibitor Treatment-Naïve Patients With Myelofibrosis: Durability of Response and Safety Beyond Week 24

  • Oral Presentation

    Clinical Benefit Associated With Biomarker Changes Indicative of Disease Modification in Patients With Myelofibrosis Treated With the BET Inhibitor Pelabresib as Monotherapy or in Combination With Ruxolitinib

  • Poster

    Pelabresib (CPI-0610) as Add-on to Ruxolitinib in Myelofibrosis: Durability of Response and Safety Beyond Week 24 in the Phase 2 MANIFEST Study

OTHER CONGRESSES

EHA 2022

European-based organization and congress promoting excellence in hematology.

09/06 - 12/06 Vienna, Austria

SOHO 2022

Annual meeting of global society of clinicians and scientists specializing in hematology.

28/09 - 01/10 Houston, TX

MorphoSys is providing the data presented at medical congresses as part of scientific exchange. The scientific information may include data/information on investigational use(s) of compounds/drugs of which the efficacy and safety have not yet been established. Information available on this website is not intended to promote or otherwise commercialize (directly or indirectly) any off-label or unapproved uses of MorphoSys’ products. Copies of congress presentations may not be reproduced without written permission from the congress and the authors.